A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
Clinical trial NCT00249145 · COMPLETED
Trial details
- NCT number
- NCT00249145
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-04-01
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.